Ultrahuman bags $70M from Qualcomm Ventures, Alpha Wave, and others
Health intelligence startup Ultrahuman said the new funding will be used to expand research and development across sensing, AI, miniaturised electronics, and health algorithms, while increasing investments in clinical science and large-scale research.
Bengaluru-based health intelligence company Ultrahuman has raised $70 million from investors including Qualcomm Ventures, Labcorp, Alpha Wave, Blume Ventures, Nexus Venture Partners, and Alteria.
According to Ultrahuman, the new funding will be used to expand research and development across sensing, AI, miniaturised electronics, and health algorithms, while increasing investments in clinical science and large-scale research.
The company said the funding marks the next phase of its evolution from a wearable health technology company to a human-computer interface company focused on the body.
Ultrahuman said its approach involves developing sensing technologies that sit close to the body to capture continuous signals and connect them with deeper biological data. It plans to use increasingly sophisticated models, trained on real-world scientific data, to turn these signals into health insights.
“For the longest time, computers have understood almost everything about the world except the person using them,” said Mohit Kumar, Founder and CEO of Ultrahuman. “We want to change that. We are building an interface that can understand the body continuously and translate its signals into intelligence that is useful in everyday life.”
The startup’s flagship product is the Ultrahuman Ring, which is supported by blood biomarkers, continuous glucose monitoring, environmental sensing, and an expanding software, AI, and research layer. Ultrahuman said these systems are designed to build a longitudinal view of human physiology rather than treat health as a collection of individual measurements.
The company believes wearable and body-based computing could become a major computing platform over the next decade, with devices continuously tracking signals related to sleep, cardiovascular health, metabolism, hormonal rhythms, blood biomarkers, recovery, and the surrounding environment. It aims to use these signals to generate insights that can help people better understand and manage their health.
“The future of AI is personal, ambient, and always on,’” said Quinn Li, Senior Vice President, Qualcomm Technologies, Inc., and global head of Qualcomm Ventures. “Ultrahuman is pioneering a new generation of personal AI devices that make personalized insights effortless. We look forward to supporting their journey as they expand the possibilities of personal AI devices.”